Pharmacogenetics of migraine : genetic variants and their potential role in migraine therapy
Fernandez, Francesca, Colson, N. J., & Griffiths, Lyn R. (2007) Pharmacogenetics of migraine : genetic variants and their potential role in migraine therapy. Pharmacogenomics, 8(6), pp. 609-622.
Migraine is a paroxysmal neurological disorder affecting up to 6% of males and 18% of females in the general population, and has been demonstrated to have a strong, but complex, genetic component. Genetic investigation of migraine provides hope that new targets for medications and individual specific therapy will be developed. The identification of polymorphisms or genetic biomarkers for disease susceptibility and treatment should aid in providing a better understanding of migraine pathology and, consequently, more appropriate and efficient treatment for migraineurs. In this review, we will discuss results investigating genetic biomarkers for migraine and their potential role in future therapy planning.
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
|Item Type:||Journal Article|
|Divisions:||Current > Institutes > Institute of Health and Biomedical Innovation|
|Copyright Owner:||Copyright 2007 Future Medicine Ltd.|
|Deposited On:||19 Sep 2013 06:50|
|Last Modified:||07 Nov 2013 00:36|
Repository Staff Only: item control page